![](/img/cover-not-exists.png)
A missense variant in complement factor B ( CFB ) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients
Chen, Haitao, Sun, Jian, Zhou, Bin, Peng, Jinxin, Xie, Qing, Liang, Xieer, Fan, Rong, Conran, Carly, Xu, Jianfeng, Ji, Yuan, Zhang, Xinxin, Sun, Li, Jia, Jidong, Wang, Guiqiang, Hou, Jinlin, Jiang, DeLanguage:
english
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.15624
Date:
January, 2020
File:
PDF, 772 KB
english, 2020